K Pharma,Inc.
|
| Code |
Sector |
Market |
Lead Underwriter |
Date of listing approval |
IPO Date |
| 4896 |
Pharmaceuticals |
Growth |
SBI SECURITIES Co.,Ltd. |
2023/09/12 |
2023/10/17 |
| 【Description】 |
| |
IPO Information |
| Opening Price |
Y875 |
Total Amount |
Y1,835,400,000 |
| IPO Price |
Y950 |
--Company |
Y1,468,320,000 |
Aggregate Value
(based on Initial Price) |
10,114
(Unit:1 million) |
--Leading Shareholder |
Y220,248,000 |
| Listed Shares(total) |
1,932,000 |
--Lead Manager |
Y146,832,000 |
| Trading Unit |
100 |
|
Offering Price PER
(based on previous period) |
-22.59 |
Offering Price PBR
(based on previous period) |
-7.74 |
| 公開価格PER(今期予想ベース) |
53.70 |
| Initial Price PER |
-20.80 |
Initial Price PBR |
-7.13 |
| New Shares |
1,680,000 |
Existing Shares |
252,000（only O.A.） |
| Shares Outstanding |
Pre IPO |
9,879,000.00 |
PostIPO |
11,559,000.00 |
| Paid Up Capital |
PreIPO |
Y100,000,000 |
PostIPO |
Y642,360,700 |
| Use of Funds Raised |
|
Financial Data |
| Units:Y1,000 |
| Fiscal Year End |
|
Revenue |
Current Profit |
Net Profit |
Net Assets |
| 2020/12 |
Consolidated |
- |
- |
- |
- |
| Non-consolidated |
- |
-269,562 |
-271,219 |
8,009 |
| 2021/12 |
Consolidated |
- |
- |
- |
- |
| Non-consolidated |
- |
-220,892 |
-228,718 |
178,891 |
| 2022/12 |
Consolidated |
- |
- |
- |
- |
| Non-consolidated |
- |
-359,233 |
-392,427 |
1,336,263 |
Interim Results
2023/06 |
Consolidated |
- |
- |
- |
- |
| Non-consolidated |
1,000,000 |
651,026 |
514,772 |
1,851,036 |
Results Forecast
2023/12 |
Consolidated |
- |
- |
- |
- |
| Non-consolidated |
1,000,000 |
266,000 |
180,000 |
- |
| Per Share |
Units:Y1 |
| Fiscal Year End |
|
Dividend |
Net Earning |
Equity |
|
| 2020/12 |
Consolidated |
0.00 |
- |
- |
|
| Non-consolidated |
-38.75 |
-84.54 |
|
| 2021/12 |
Consolidated |
0.00 |
- |
- |
|
| Non-consolidated |
-30.09 |
-107.03 |
|
| 2022/12 |
Consolidated |
0.00 |
- |
- |
|
| Non-consolidated |
-42.06 |
-122.77 |
|
| Fiscal Year End |
|
Dividend |
Net Earning |
Equity |
|
Interim Results
2023/06 |
Consolidated |
|
- |
- |
|
| Non-consolidated |
52.11 |
- |
|
Results Forecast
2023/12
| Consolidated
| 0.00 |
- |
- |
|
| Non-consolidated |
17.69 |
- |
|
Comment |
| ■Over allotment(252,000) |
| Consolidated Subsidiaries |
| Name |
Address |
| Underwriters |
| Allocation |
Underwriter |
Tel |
| 85% |
SBI SECURITIES Co.,Ltd. |
03-5562-7210 |
| 10% |
Okasan |
03-3272-2211 |
| 3% |
SMBC Nikko |
03-5644-3111 |
| 1% |
IwaiCosmo Securities Co.,Ltd. |
06-6229-2890 |
| 0.5% |
Kyokuto |
03-3667-9171 |
| 0.3% |
Matsui |
03-5216-0606 |
| 0.2% |
Rakuten Securities |
03-6406-2681 |
| Data |
| Date of incorporation |
2016/11/01 |
| Company address |
Tokyo 106-0032 |
| Telephone |
03-6629-3380 |
| President |
|
| Homepage |
https://www.kpharma.co.jp/ |
| Auditor |
Azsa |
|
|
| Major Shareholders |
| Shareholder Name |
Ratio |
| |
22.03% |
| |
13.71% |
| |
11.59% |
| |
11.59% |
| |
10.34% |
| |
6.47% |
| |
5.88% |
| |
5.80% |
| |
4.97% |
| |
2.26% |
| Number of Employees |
16 as of 2023/08/31 |
| Birth Date of Representative |
1960/07/30 |
|
|
IPO最新情報、セミナー・イベント情報などをタイムリーにお届けします。
|
|
IPO関連ニュースをX（旧Twitter）でも掲載中。初値予想アンケートも実施中です！
|
|
今後の躍進が期待される注目銘柄のアナリストレポートをご覧いただけます。
|
|
個人投資家向けIRセミナーを開催しませんか？開催希望企業募集中！
|
|
